PRECIGEN, INC. Increase (Decrease) in Employee Related Liabilities
PRECIGEN, INC. (PGEN) reported Increase (Decrease) in Employee Related Liabilities of -$330.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities · last filed 2026-08-04
- PRECIGEN, INC. increase (decrease) in employee related liabilities for the quarter ending 2026-06-30 was $1.94M, a 324.02% increase year-over-year.
- PRECIGEN, INC. increase (decrease) in employee related liabilities for the quarter ending 2026-03-31 was -$2.27M, a 288.70% decline year-over-year.
- PRECIGEN, INC. increase (decrease) in employee related liabilities for the quarter ending 2025-12-31 was $33.00K, a 98.17% decline year-over-year.
- PRECIGEN, INC. increase (decrease) in employee related liabilities for the quarter ending 2025-09-30 was $4.97M.
- PRECIGEN, INC. increase (decrease) in employee related liabilities for fiscal 2025 was $6.66M, a 111.83% increase from fiscal 2024.
- PRECIGEN, INC. increase (decrease) in employee related liabilities for fiscal 2024 was $3.15M, a 39.83% decline from fiscal 2023.
- PRECIGEN, INC. increase (decrease) in employee related liabilities for fiscal 2023 was $5.23M.
- PRECIGEN, INC. increase (decrease) in employee related liabilities for fiscal 2022 was -$37.00K, a 101.30% decline from fiscal 2021.
| Period end | Increase (Decrease) in Employee Related Liabilities 3 month | Increase (Decrease) in Employee Related Liabilities 6 month | Increase (Decrease) in Employee Related Liabilities 9 month | Increase (Decrease) in Employee Related Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$330.00K 10-Q · filed 2026-08-04 | -$297.00K derived: sum of 3 quarters · filed 2026-08-04 | $4.67M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | -$2.27M 10-Q · filed 2026-05-13 | -$2.24M derived: sum of 2 quarters · filed 2026-05-13 | $2.73M derived: sum of 3 quarters · filed 2026-05-13 | $3.19M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $5.00M derived: sum of 2 quarters · filed 2026-03-25 | $5.46M derived: sum of 3 quarters · filed 2026-08-04 | $6.66M 10-K · filed 2026-03-25 |
| 2025-09-30 | $4.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $5.42M derived: sum of 2 quarters · filed 2026-08-04 | $6.63M 10-Q · filed 2025-11-13 | $8.44M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $458.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $1.66M 10-Q · filed 2026-08-04 | $3.47M derived: sum of 3 quarters · filed 2026-08-04 | $3.34M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $1.20M 10-Q · filed 2026-05-13 | $3.01M derived: sum of 2 quarters · filed 2026-05-13 | $2.88M derived: sum of 3 quarters · filed 2026-05-13 | $2.63M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $1.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $1.68M derived: sum of 2 quarters · filed 2026-03-25 | $1.42M derived: sum of 3 quarters · filed 2026-03-25 | $3.15M 10-K · filed 2026-03-25 |
| 2024-09-30 | -$130.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$384.00K derived: sum of 2 quarters · filed 2025-11-13 | $1.34M 10-Q · filed 2025-11-13 | $2.94M derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-06-30 | -$254.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $1.47M 10-Q · filed 2025-08-12 | $3.08M derived: sum of 3 quarters · filed 2026-03-25 | $4.89M derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-03-31 | $1.72M 10-Q · filed 2025-05-14 | $3.33M derived: sum of 2 quarters · filed 2026-03-25 | $5.14M derived: sum of 3 quarters · filed 2026-03-25 | $5.01M derived: sum of 4 quarters · filed 2026-03-25 |
| 2023-12-31 | $1.61M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $3.42M derived: sum of 2 quarters · filed 2026-03-25 | $3.29M derived: sum of 3 quarters · filed 2026-03-25 | $5.23M 10-K · filed 2026-03-25 |
| 2023-09-30 | $1.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $1.68M derived: sum of 2 quarters · filed 2024-11-14 | $3.62M 10-Q · filed 2024-11-14 | $4.16M derived: sum of 4 quarters · filed 2025-03-19 |
| 2023-06-30 | -$132.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $1.80M 10-Q · filed 2024-08-14 | $2.35M derived: sum of 3 quarters · filed 2025-03-19 | $2.78M derived: sum of 4 quarters · filed 2025-03-19 |
| 2023-03-31 | $1.94M 10-Q · filed 2024-05-14 | $2.48M derived: sum of 2 quarters · filed 2025-03-19 | $2.91M derived: sum of 3 quarters · filed 2025-03-19 | $5.36M derived: sum of 4 quarters · filed 2025-03-19 |
| 2022-12-31 | $541.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | $978.00K derived: sum of 2 quarters · filed 2025-03-19 | $3.42M derived: sum of 3 quarters · filed 2025-03-19 | -$37.00K 10-K · filed 2025-03-19 |
| 2022-09-30 | $437.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $2.88M derived: sum of 2 quarters · filed 2023-11-09 | -$578.00K 10-Q · filed 2023-11-09 | $2.58M derived: sum of 4 quarters · filed 2024-03-19 |
| 2022-06-30 | $2.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$1.01M 10-Q · filed 2023-08-09 | $2.14M derived: sum of 3 quarters · filed 2024-03-19 | $2.46M derived: sum of 4 quarters · filed 2024-03-19 |
| 2022-03-31 | -$3.46M 10-Q · filed 2023-05-10 | -$305.00K derived: sum of 2 quarters · filed 2024-03-19 | $18.00K derived: sum of 3 quarters · filed 2024-03-19 | $1.28M derived: sum of 4 quarters · filed 2024-03-19 |
| 2021-12-31 | $3.16M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $3.48M derived: sum of 2 quarters · filed 2024-03-19 | $4.75M derived: sum of 3 quarters · filed 2024-03-19 | $2.85M 10-K · filed 2024-03-19 |
| 2021-09-30 | $323.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $1.59M derived: sum of 2 quarters · filed 2022-11-09 | -$304.00K 10-Q · filed 2022-11-09 | $512.00K derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-06-30 | $1.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$627.00K 10-Q · filed 2022-08-08 | $189.00K derived: sum of 3 quarters · filed 2023-03-06 | $24.00K derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-03-31 | -$1.89M 10-Q · filed 2022-05-09 | -$1.08M derived: sum of 2 quarters · filed 2023-03-06 | -$1.24M derived: sum of 3 quarters · filed 2023-03-06 | -$741.00K derived: sum of 4 quarters · filed 2023-03-06 |
| 2020-12-31 | $816.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $651.00K derived: sum of 2 quarters · filed 2023-03-06 | $1.15M derived: sum of 3 quarters · filed 2023-03-06 | -$789.00K 10-K · filed 2023-03-06 |
| 2020-09-30 | -$165.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $336.00K derived: sum of 2 quarters · filed 2021-11-08 | -$1.60M 10-Q · filed 2021-11-08 | $3.05M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $501.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$1.44M 10-Q · filed 2021-08-09 | $3.21M derived: sum of 3 quarters · filed 2022-03-01 | $4.09M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | -$1.94M 10-Q · filed 2021-05-10 | $2.71M derived: sum of 2 quarters · filed 2022-03-01 | $3.59M derived: sum of 3 quarters · filed 2022-03-01 | $5.03M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $4.65M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $5.53M derived: sum of 2 quarters · filed 2022-03-01 | $6.97M derived: sum of 3 quarters · filed 2022-03-01 | $5.19M 10-K · filed 2022-03-01 |
| 2019-09-30 | $882.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $2.32M derived: sum of 2 quarters · filed 2020-11-09 | $535.00K 10-Q · filed 2020-11-09 | -$12.64M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $1.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$347.00K 10-Q · filed 2020-08-10 | -$13.52M derived: sum of 3 quarters · filed 2021-03-01 | -$3.56M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | -$1.79M 10-Q · filed 2020-05-11 | -$14.96M derived: sum of 2 quarters · filed 2021-03-01 | -$5.00M derived: sum of 3 quarters · filed 2021-03-01 | -$2.25M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | -$13.18M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$3.21M derived: sum of 2 quarters · filed 2021-03-01 | -$466.00K derived: sum of 3 quarters · filed 2021-03-01 | $4.38M 10-K · filed 2021-03-01 |
| 2018-09-30 | $9.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $12.71M derived: sum of 2 quarters · filed 2019-11-12 | $17.56M 10-Q · filed 2019-11-12 | $12.80M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $2.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $7.60M 10-Q · filed 2019-08-09 | $2.84M derived: sum of 3 quarters · filed 2020-03-02 | $4.88M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $4.85M 10-Q · filed 2019-05-09 | $94.00K derived: sum of 2 quarters · filed 2020-03-02 | $2.14M derived: sum of 3 quarters · filed 2020-03-02 | $2.46M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | -$4.76M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$2.71M derived: sum of 2 quarters · filed 2020-03-02 | -$2.39M derived: sum of 3 quarters · filed 2020-03-02 | -$1.47M 10-K · filed 2020-03-02 |
| 2017-09-30 | $2.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $2.37M derived: sum of 2 quarters · filed 2018-11-08 | $3.29M 10-Q · filed 2018-11-08 | -$1.11M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | $322.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2018-08-13 | $1.25M 10-Q · filed 2018-08-13 | -$3.15M derived: sum of 3 quarters · filed 2019-03-01 | -$1.61M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | $924.00K 10-Q/A · filed 2018-08-13 | -$3.48M derived: sum of 2 quarters · filed 2019-03-01 | -$1.94M derived: sum of 3 quarters · filed 2019-03-01 | -$705.00K derived: sum of 4 quarters · filed 2019-03-01 |
| 2016-12-31 | -$4.40M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$2.86M derived: sum of 2 quarters · filed 2019-03-01 | -$1.63M derived: sum of 3 quarters · filed 2019-03-01 | -$12.40M 10-K · filed 2019-03-01 |
| 2016-09-30 | $1.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $2.77M derived: sum of 2 quarters · filed 2017-11-09 | -$8.00M 10-Q · filed 2017-11-09 | -$3.40M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-06-30 | $1.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$9.54M 10-Q · filed 2017-08-09 | -$4.95M derived: sum of 3 quarters · filed 2018-03-01 | -$3.15M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-03-31 | -$10.77M 10-Q · filed 2017-05-10 | -$6.18M derived: sum of 2 quarters · filed 2018-03-01 | -$4.38M derived: sum of 3 quarters · filed 2018-03-01 | $15.00K derived: sum of 4 quarters · filed 2018-03-01 |
| 2015-12-31 | $4.60M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $6.39M derived: sum of 2 quarters · filed 2018-03-01 | $10.79M derived: sum of 3 quarters · filed 2018-03-01 | $10.49M 10-K · filed 2018-03-01 |
| 2015-09-30 | $1.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $6.19M derived: sum of 2 quarters · filed 2016-11-09 | $5.89M 10-Q · filed 2016-11-09 | $6.94M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $4.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $4.10M 10-Q · filed 2016-08-09 | $5.14M derived: sum of 3 quarters · filed 2017-03-01 | $6.83M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | -$297.00K 10-Q · filed 2016-05-10 | $745.00K derived: sum of 2 quarters · filed 2017-03-01 | $2.44M derived: sum of 3 quarters · filed 2017-03-01 | $3.77M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $2.73M derived: sum of 2 quarters · filed 2017-03-01 | $4.07M derived: sum of 3 quarters · filed 2017-03-01 | $1.59M 10-K · filed 2017-03-01 |
| 2014-09-30 | $1.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $3.02M derived: sum of 2 quarters · filed 2015-11-09 | $545.00K 10-Q · filed 2015-11-09 | $2.01M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | $1.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$1.15M 10-Q · filed 2015-08-10 | $321.00K derived: sum of 3 quarters · filed 2016-02-29 | $691.00K derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | -$2.48M 10-Q · filed 2015-05-11 | -$1.01M derived: sum of 2 quarters · filed 2016-02-29 | -$642.00K derived: sum of 3 quarters · filed 2016-02-29 | -$1.19M derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | $1.47M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $1.84M derived: sum of 2 quarters · filed 2016-02-29 | $1.29M derived: sum of 3 quarters · filed 2016-02-29 | $1.30M 10-K · filed 2016-02-29 |
| 2013-09-30 | $370.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | -$179.00K derived: sum of 2 quarters · filed 2014-11-13 | -$167.00K 10-Q · filed 2014-11-13 | $359.00K derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-06-30 | -$549.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | -$537.00K 10-Q · filed 2014-08-14 | -$11.00K derived: sum of 3 quarters · filed 2015-03-02 | $631.00K derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-03-31 | $12.00K 10-Q · filed 2014-05-09 | $538.00K derived: sum of 2 quarters · filed 2015-03-02 | $1.18M derived: sum of 3 quarters · filed 2015-03-02 | |
| 2012-12-31 | $526.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $1.17M derived: sum of 2 quarters · filed 2015-03-02 | $2.44M 10-K · filed 2015-03-02 | |
| 2012-09-30 | $642.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-11-07 | $1.92M 10-Q · filed 2013-11-07 | ||
| 2012-06-30 | $1.27M 10-Q/A · filed 2013-10-21 | |||
| 2011-12-31 | -$2.25M 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |